Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$1.69B |
| 2 |
SPYM
State Street SPDR Portfolio S&P 500 ETF
SPYM
|
+$1.32B |
| 3 |
Vanguard Total Bond Market
BND
|
+$1.21B |
| 4 |
SPDR Gold Trust
GLD
|
+$970M |
| 5 |
State Street SPDR Portfolio S&P 500 Growth ETF
SPYG
|
+$842M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$7.66B |
| 2 |
Invesco QQQ Trust
QQQ
|
+$5.23B |
| 3 |
Accenture
ACN
|
+$1.14B |
| 4 |
Advanced Micro Devices
AMD
|
+$1.13B |
| 5 |
Vanguard Short-Term Bond ETF
BSV
|
+$635M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.44% |
| 2 | Financials | 11.15% |
| 3 | Consumer Discretionary | 8.06% |
| 4 | Healthcare | 8.02% |
| 5 | Communication Services | 7.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ONCY
5526
Oncolytics Biotech
ONCY
$95.5M
| $373K | ﹤0.01% |
426,518
+43,172
| +11% | +$46.7K |
|
5527
Vor Biopharma
VOR
$1.05B
| $372K | ﹤0.01% |
28,463
+24,007
| +539% | +$447K |
|
5528
Acme United Corp
ACU
$217M
| $370K | ﹤0.01% |
9,184
+2,418
| +36% | +$93.1K |
|
5529
KULR Technology Group
KULR
$122M
| $369K | ﹤0.01% |
124,797
-125,235
| -50% | -$460K |
|
5530
Invesco DB Oil Fund
DBO
$387M
| $369K | ﹤0.01% |
30,212
+185
| +0.6% | +$2.37K |
|
5531
Tradr 1.25X NVDA Bear Daily ETF
NVDS
$16.6M
| $366K | ﹤0.01% |
13,066
+4,999
| +62% | +$161K |
|
5532
Citizens Financial Services
CZFS
$365M
| $365K | ﹤0.01% |
6,406
+875
| +16% | +$49.8K |
|
|
TULP
5533
Bloomia Holdings
TULP
$15.6M
| $363K | ﹤0.01% |
105,309
+22,700
| +27% | +$91K |
|
5534
Eledon Pharmaceuticals
ELDN
$276M
| $363K | ﹤0.01% |
240,545
+1,386
| +0.6% | +$3.29K |
|
|
TVRD
5535
Tvardi Therapeutics
TVRD
$23.8M
| $363K | ﹤0.01% |
84,466
+80,680
| +2,131% | +$723K |
|
|
POWR
5536
iShares U.S. Power Infrastructure ETF
POWR
$444M
| $362K | ﹤0.01% |
15,402
+5,891
| +62% | +$147K |
|
5537
Stem
STEM
$50M
| $362K | ﹤0.01% |
24,074
+652
| +3% | +$12.5K |
|
5538
CB Financial Services
CBFV
$184M
| $362K | ﹤0.01% |
10,386
+1,324
| +15% | +$44.9K |
|
5539
WisdomTree Yield Enhanced US Short-Term Aggregate Bond Fund
SHAG
$47.2M
| $360K | ﹤0.01% |
7,498
-337
| -4% | -$16.2K |
|
5540
LENSAR
LNSR
$66M
| $360K | ﹤0.01% |
30,922
+14,645
| +90% | +$167K |
|
|
OPENZ
5541
Opendoor Technologies Inc Series Z Warrants
OPENZ
$5.53M
| $358K | ﹤0.01% |
+895,907
| New | +$542K |
|
5542
Invesco CurrencyShares Canadian Dollar Trust
FXC
$72.6M
| $358K | ﹤0.01% |
5,026
-4
| -0.1% | -$280 |
|
5543
First Trust Germany AlphaDEX Fund
FGM
$96.6M
| $357K | ﹤0.01% |
5,722
-47
| -0.8% | -$2.79K |
|
|
CAN
5544
Canaan Creative
CAN
$192M
| $356K | ﹤0.01% |
516,162
-1,891,293
| -79% | -$2.17M |
|
5545
Senseonics Holdings Inc
SENS
$262M
| $355K | ﹤0.01% |
64,391
+48,593
| +308% | +$338K |
|
5546
China Automotive Systems
CAAS
$132M
| $355K | ﹤0.01% |
83,287
+7,993
| +11% | +$34.2K |
|
5547
Twin Disc
TWIN
$335M
| $355K | ﹤0.01% |
21,260
+7,227
| +52% | +$112K |
|
|
MXE
5548
Mexico Equity and Income Fund
MXE
$58.2M
| $354K | ﹤0.01% |
28,581
+4,633
| +19% | +$54.9K |
|
|
GGT
5549
Gabelli Multimedia Trust
GGT
$169M
| $354K | ﹤0.01% |
84,212
-14,365
| -15% | -$59K |
|
5550
Coherus Oncology
CHRS
$225M
| $353K | ﹤0.01% |
248,394
+18,037
| +8% | +$26.3K |
|
Similar funds
Morgan Stanley's Q4 2025 Portfolio in Review
As of Q4 2025, Morgan Stanley held 8,587 positions worth $1.67T, up 1.4% from $1.65T the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Morgan Stanley's Q4 2025 filing shows 427 new, 3,948 increased, 2,961 reduced and 384 closed positions. Its largest new stake was Medline Inc: 15,162,060 shares worth $637M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $7.66B.
By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 23% a quarter earlier, followed by Financials and Consumer Discretionary.
- Morgan Stanley's largest Q4 2025 buy was Medline Inc: 15,162,060 shares worth $637M.
- Morgan Stanley added most to Vanguard FTSE Developed Markets ETF in Q4 2025, an estimated $1.69B increase.
- Morgan Stanley's biggest Q4 2025 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $7.66B.
- Morgan Stanley fully exited Mr. Cooper in Q4 2025, selling an estimated $312M.
- Morgan Stanley's ten largest holdings make up 22% of its $1.67T portfolio in Q4 2025.
- Morgan Stanley opened 427 new positions and closed 384 in Q4 2025.
- Morgan Stanley's portfolio value rose 1.4% quarter-over-quarter to $1.67T.
Based on Morgan Stanley's 13F filing for Q4 2025, filed 13 Feb 2026.